73 results
Page 2 of 4
S-3
EX-1.2
y3npqhzr2w hx6l2dtcn
1 Jul 22
Shelf registration
4:13pm
DEF 14A
uvcawl mmvh
28 Apr 22
Definitive proxy
8:36am
424B3
u26f1vnwaynxj2l2zk7g
31 Mar 22
Prospectus supplement
11:42am
POS AM
m6ex9ltp
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
o6fahk
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.1
86xb85l92 7v0f6321r
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
6sqkf7wzb
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
EX-99
02hl 5u17o9otozqom
1 Dec 21
Prospectus supplement
8:25am
8-K
hd534k opok79ve7hjhf
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
EX-99.1
l8eldfw bu4mdosl
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
wjpa1t 8jpd5d7
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
ecnsjkqv9t7c6hvca
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
424B3
wbgldaupthlm
5 Aug 21
Prospectus supplement
4:26pm
424B3
15mpcn312lsqwa
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.10
gu0x6a4 80ojk8
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm